Website

Solana Company (HSDT) is a Biotechnology: Electromedical & Electrotherapeutic Apparatus company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for HSDT, including 2 earnings updates, 2 SEC filings and 1 press release or news item. The most recent was published Nov 12, 2026.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

HSDT rankings

Financial highlights

Full financials
Revenue, TTM
$14.73M
Revenue growth
+1465.9%
Net income, TTM
$300.66M
Net margin
2040.4%
Cash
$1.13M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks33+67%
2026-05-17: 32026-05-24: 92026-05-31: 22026-06-07: 02026-06-14: 12026-06-21: 02026-06-28: 12026-07-05: 02026-07-12: 22026-07-19: 02026-07-26: 02026-08-02: 12026-08-09: 42026-08-16: 12026-08-23: 12026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 32026-10-04: 02026-10-11: 02026-10-18: 12026-10-25: 02026-11-01: 02026-11-08: 4
2026-05-172026-11-08
Mix1090d
  • SEC Filings4(40%)
  • Other2(20%)
  • Earnings2(20%)
  • Insider1(10%)
  • Offering1(10%)
Activity · 52 weeks7741 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

HSDT FAQ

10 questions
  • What does Solana Company do?
    Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown...
  • What is the latest news on HSDT?
    In the last 30 days Quantisnow tracked 5 wire items for HSDT: 2 earnings updates, 2 SEC filings and 1 press release or news item. The most recent was published on November 12, 2026.
  • What is HSDT revenue?
    Solana Company (HSDT) reported $14.73M of revenue for the twelve months ended Sep 30, 2026. That is up 1465.9% from the year before. Revenue for fiscal 2025 was $6.02M.
  • Is HSDT profitable?
    Yes. Solana Company earned $300.66M in net income for the twelve months ended Sep 30, 2026, a net margin of 2040.4%.
  • How much cash and debt does HSDT have?
    Solana Company reported $1.13M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does HSDT stock trade?
    Solana Company (HSDT) is listed on NASDAQ.
  • What sector and industry is HSDT in?
    Solana Company operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • What are analysts saying about HSDT?
    Across the last 3 analyst actions on Solana Company, there were 0 upgrades and 1 downgrade. The most recent action was from B. Riley Securities: Buy with a $3.00 price target on 2026-04-23. Recent price targets range from $3.00 to $4.00.
  • What companies are similar to HSDT?
    Notable peers in the same industry include NXL (Nexalin Technology Inc.), NPCE (Neuropace Inc.), ECOR (electroCore Inc.), MDT (Medtronic plc.). Compare HSDT side-by-side with any of them on Quantisnow.
  • How can I track HSDT on Quantisnow?
    Quantisnow aggregates Solana Company's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HSDT to receive live email and push alerts on every new disclosure.